Studies have shown that PS can effectively alleviate Staphylococcus aureus-induced mastitis by inhibiting the activation of pro-inflammatory signaling pathways such as NF-κB/NLRP3, reducing the release of inflammatory factors such as IL-1β and TNF-α. Here, IL1B is linked to mastitis.